Founded in 2010 by Cécile Vienney (CEO) and 3 orthopedic surgeons, Hyprevention is a French start-up located in Bordeaux that develops, manufactures and markets implantable medical devices to reinforce weaken bone by osteoporosis or cancer thanks to the STRUTPLASTY® Technology. In 2021, Hyprevention INC was established in New-York - USA to promote V-STRUT© Vertebral Implant FDA cleared. www.hyprevention.com www.hypreventionusa.com V-STRUT© Vertebral Implant is indicated to treat vertebral fractures. The device is made of PEEK polymer, close to normal bone, and presents a pedicle anchorage to reinforce the full vertebrae. It is a unique solution on the market aiming to rebalance antero-posterior loading and stress. With aging, bone quality decreases due to osteoporosis, increasing the risk of vertebral compression fractures). Osteoporosis is the most common disease affecting the elderly population. As a result, the vertebral body is at risk of fracture with about 750 000 vertebral compression fractures per year in the US alone among which 250 000 require treatment, Y-STRUT® Hip Implant (not available in US) is intended to prevent a contra-lateral fracture in patients at risk due to bone fragility linked to osteoporosis. Implementation of a contralateral Y-STRUT is performed during the same anesthesia as practiced for the treatment of the original fracture. The duration of hospitalization remains unchanged. Contralateral Y-STRUT requires no specific rehabilitation. Hip fracture affects more than 2 million people worldwide every year. This number will reach more than 6 million in 2050, due to an aging and increasing population. At 1 year, 9% of patients will have a contra-lateral fracture, at 5 years this rises to 20%. After a second contralateral fracture, loss of autonomy is almost certain to prevent a return home. Mortality is multiplied by 2. The prevention of hip fracture improves the quality of life of older people by allowing them to retain their autonomy.